DIETARY LIPIDS--EFFECTS ON LIPID-LIPOPROTEIN METABOLISM
DIETARY LIPIDS--EFFECTS ON LIPID-LIPOPROTEIN METABOLISM
批准号:
3353895
负责人:
D ROGER ILLINGWORTH
金额:
$62.66万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 1992-11-30
关键词:
antihyperlipoproteinemic agent apolipoproteins blood chemistry blood lipoprotein metabolism cholesterol dietary lipid eicosanoid metabolism eicosanoids high density lipoproteins human subject hypercholesterolemia hypertriglyceridemia leukocytes lipid metabolism low density lipoprotein marine animal oil mevalonate nutrition education nutrition related tag omega 3 fatty acid platelets saturated fatty acids seafood sterols triglycerides unsaturated fatty acids urinalysis very low density lipoprotein
中文摘要
我们建议进行一系列综合的临床和生化调查
英文摘要
We propose an integrated series of clinical and biochemical investigations
to better delineate the effects of specific dietary lipids on lipid and
lipoprotein metabolism in human subjects. The influence of diets in which
monounsaturated fatty acids represent the main source of fat will be
investigated in terms of their lipid lowering effects compared to similar
diets containing 30% of calories from omega-6 polyunsaturated fatty acids
or primarily saturated fatty acids and both of these compared to a low fat
diet. All diets will be fed to subjects with primary hypercholesterolemia
and parameters of lipoprotein metabolism to be studied will include
125I-LDL turnover, cholesterol homeostasis assessed by serum and urinary
excretion of mevalonic acid and cholesterol synthesis in freshly isolated
mononuclear leukocytes. These four diets will be fed to subjects consuming
a cholesterol-free diet and in the presence of 600 mg/day of dietary
cholesterol. The metabolic effects of long chain polyunsaturated fatty
acids derived from fish oil will be examined in studies outlined in Project
2. These studies aim to examine whether the hypotriglyceridemic effects of
long-chain omega-3 polyunsaturated fatty acids are due primarily to
eicosapentaenoic acid or docosahexaenoic acid by determining if these
purified fatty acids (as dietary constituents) prevent carbohydrate induced
hypertriglyceridemia. The mechanisms responsible for the reduction of HDL
concentrations in hypercholesterolemic subjects fed a low cholesterol fish
oil will be examined by performing kinetic studies with 125I-labeled HDL.
The influence of fish oils on prostanoid formation will be examined in
collaborative studies. These studies should further our knowledge
concerning the anti-atherosclerotic effects of long chain omega-3 fatty
acids. The influence of sterols on plasma lipid and lipoprotein
concentrations will be examined in normal and hypercholesterolemic subjects
fed diets supplemented with seafood sterols. Finally, the fourth project
aims to examine the hypocholesterolemic effects of three phases of a
prudent diet in volunteer subjects, establish a recipe development
laboratory, and prospectively assess the effectiveness of dietary
counseling as an adjunct to long-term control of plasma lipids in an
outpatient setting. Overall, these studies should enhance our knowledge
concerning the clinical and metabolic effects of specific dietary lipids
and have direct therapeutic application to treatment of subjects with
hypercholesterolemia.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia.
洛伐他汀和辛伐他汀对杂合子家族性高胆固醇血症患者的降血脂作用比较。
DOI:
10.1016/0021-9150(92)90037-h
发表时间:
1992
期刊:
Atherosclerosis
影响因子:
5.3
作者:
[Illingworth,DR, Bacon,S, Pappu,AS, Sexton,GJ]
通讯作者:
Sexton,GJ
Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis.
测量人体胆固醇合成时血浆甲羟戊酸水平与氘吸收之间的对应关系。
DOI:
10.1111/j.1365-2362.1992.tb01512.x
发表时间:
1992
期刊:
European journal of clinical investigation
影响因子:
5.5
作者:
[Jones,PJ, Pappu,AS, Illingworth,DR, Leitch,CA]
通讯作者:
Leitch,CA
New horizons in combination drug therapy for hypercholesterolemia.
高胆固醇血症联合药物治疗的新视野。
DOI:
10.1159/000174550
发表时间:
1989
期刊:
Cardiology
影响因子:
1.9
作者:
[Illingworth,DR]
通讯作者:
Illingworth,DR
Dietary treatment of familial hypercholesterolemia.
家族性高胆固醇血症的饮食治疗。
DOI:
--
发表时间:
1989
期刊:
Arteriosclerosis (Dallas, Tex.)
影响因子:
--
作者:
[Connor,WE, Connor,SL]
通讯作者:
Connor,SL
Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia.
n-3 脂肪酸对原发性高脂蛋白血症的降血脂作用。
DOI:
10.1111/j.1365-2796.1989.tb01441.x
发表时间:
1989
期刊:
Journal of internal medicine. Supplement
影响因子:
--
作者:
[Illingworth,DR, Connor,WE, Hatcher,LF, Harris,WS]
通讯作者:
Harris,WS
共 26 条
Effects of simvastatin on postprandial hyperlipidemia
-
批准号:6465859
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2000
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
REGULAR AND SUSTAINED RELEASE SIMVISTATIN IN HYPERCHOLESTEROLEMIA
-
批准号:6116977
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
SIMVASTATIN ON STEROID HORMONE PRODUCTION IN MEN WITH HYPERCHOLESTEROLEMIA
-
批准号:6116946
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6116953
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
METABOLIC STUDY ON THE HYPOLIPIDEMIC EFFECTS OF DRUGS WHICH INHIBIT CHOLESTEROL
-
批准号:6116945
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
BAYW6228 COMPARED TO PLACEBO & LOVASTATIN IN PTS W/ PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6116950
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
LIPID METABOLISM IN ABETALIPOPROTEINEMIA
-
批准号:6116969
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
CHOLESTEROL REDUCTION WITH LDL APHERESIS IN HYPERCHOLESTEROLEMIA
-
批准号:6116920
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF ATORVASTATIN IN TYPE III HYPERLIPIDEMIA--OPEN EXTENSION STUDY
-
批准号:6116952
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER TRIAL OF MEVINOLIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6116918
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER STUDY OF MEVINOLIN VS CHOLESTYRAMINE IN HYPERCHOLESTEROLEMIA
-
批准号:6116916
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF GEMFIBROZIL, SIMVASTATIN, AND ATORVASTATIN IN TYPE III HYPERLIPIDEMIA
-
批准号:6248054
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6248079
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
U S/JAPAN CONFERENCE ON OXIDANTS AND ANTIOXIDANTS
-
批准号:2592895
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
LIPID METABOLISM IN ABETALIPOPROTEINEMIA
-
批准号:6278164
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER STUDY OF MEVINOLIN VS CHOLESTYRAMINE IN HYPERCHOLESTEROLEMIA
-
批准号:6278111
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6248059
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF ATORVASTATIN IN TYPE III HYPERLIPIDEMIA--OPEN EXTENSION STUDY
-
批准号:6248078
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER STUDY OF MEVINOLIN VS CHOLESTYRAMINE IN HYPERCHOLESTEROLEMIA
-
批准号:6248014
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
BAYW6228 COMPARED TO PLACEBO & LOVASTATIN IN PTS W/ PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6278145
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
海外基金